Cymbalta Withdrawal Lawsuit Announcement
Schmidt & Clark, LLP, a nationally recognized products liability law firm, announced recently that it is now currently accepting new clients who have taken the prescription medication Cymbalta and subsequently suffered from severe withdrawal symptoms. To see if you qualify, you can visit their Cymbalta Withdrawal Lawsuit website.
What’s the Problem?
Cymbalta is an antidepressant medication approved to treat major depressive and anxiety disorders, chronic musculoskeletal pain including discomfort from osteoarthritis and chronic lower back pain, as well as diabetic peripheral neuropathy and fibromyalgia. The drug is manufactured by Eli Lilly & Co., and was first approved by the U.S. Food & Drug Administration (FDA) in 2004. As forum members, we all know that Cymbalta has been linked to severe withdrawal symptoms in patients who discontinue treatment of the drug. Clinically referred to as Cymbalta Discontinuation Syndrome, this condition’s symptoms include:
• “Brain Zaps” (electric shock sensations)
• Suicidal Thoughts
• Involuntary Crying or Laughing
• Persistent ringing in the ears (Tinnitus)
• Mood swings
• Limb pain
According to an FDA Warning, Cymbalta Discontinuation Syndrome can cause “injury, distress and life management impacts” when a patient quits taking the drug. Symptoms can persist for weeks or even months after discontinuing Cymbalta, and can adversely affect the person’s job function and personal relationships.
The Cymbalta Prescribing Information states: “A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.” However, gradually stepping down the dosage of Cymbalta is virtually impossible because the drug is only available in 20, 30 and 60mg capsules that cannot be divided or cut in half.
Cymbalta Class Action Lawsuit
In October 2012, the first Cymbalta Class Action Lawsuit was filed against Eli Lilly in federal district court in California. The case, which was entered on behalf of plaintiffs in CA, NY, MA and MO, alleges that Cymbalta causes an unreasonably large number of patients who attempt to stop taking it to experience sudden and severe withdrawal symptoms (as opposed to the 1% listed on the product’s labeling).
Do I Have a Cymbalta Lawsuit?
The Products Liability Litigation Group at the law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Cymbalta Lawsuits. The firm is pursuing individual litigation nationwide and currently accepting new Cymbalta withdrawal cases in all 50 states. If you experienced severe withdrawal symptoms after quitting or attempting to quit Cymbalta, we suggest that you visit their website. The site includes detailed information, news and more regarding this drug and the litigation surrounding it.
About Schmidt & Clark, LLP
Schmidt & Clark, LLP focuses on helping individuals and families. The firm has built a reputation for success, and represents their clients in group and individual lawsuits nationwide. Although Schmidt & Clark, LLP is national in scope, they level the playing field for their clients by providing them with access to a level of professional legal representation previously available only to large corporations, while still providing personal attention to each client.
For more information on the Cymbalta lawsuit or Schmidt & Clark, LLP, please visit:
www.schmidtandclark.com/cymbalta-withdrawal or call the law firm directly, toll free 24 hrs/day (866) 588-0600.